Sonja R. Surman

1.8k total citations
41 papers, 1.4k citations indexed

About

Sonja R. Surman is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Sonja R. Surman has authored 41 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Epidemiology, 33 papers in Infectious Diseases and 2 papers in Surgery. Recurrent topics in Sonja R. Surman's work include Respiratory viral infections research (40 papers), Virology and Viral Diseases (31 papers) and Viral Infections and Vectors (25 papers). Sonja R. Surman is often cited by papers focused on Respiratory viral infections research (40 papers), Virology and Viral Diseases (31 papers) and Viral Infections and Vectors (25 papers). Sonja R. Surman collaborates with scholars based in United States, Germany and Australia. Sonja R. Surman's co-authors include Peter L. Collins, Mario H. Skiadopoulos, Brian R. Murphy, Jeffrey M. Riggs, Emérito Amaro-Carambot, Ursula J. Buchholz, Josephine M. McAuliffe, William R. Elkins, Marisa St. Claire and Stéphane Biacchesi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of Virology.

In The Last Decade

Sonja R. Surman

41 papers receiving 1.4k citations

Peers

Sonja R. Surman
Comparison fields: 5 of 58
  • Epidemiology 1.3k
  • Infectious Diseases 915
  • Pulmonary and Respiratory Medicine 144
  • Animal Science and Zoology 134
  • Immunology 134
Replace Valerie B. Randolph with:
Valerie B. Randolph United States
Roderick S. Tang United States
Cai-Yen Firestone United States
Josephine M. McAuliffe United States
Mary Lou Clements‐Mann United States
R M Chanock United States
Selma Yüksel Netherlands
Loïc Legrand France
Joshua M. DiNapoli United States
Brian R. Murphy United States
Valerie B. Randolph United States View profile →
Citations per field, relative to Sonja R. Surman
Sonja R. Surman · 1×
Citations per year, relative to Sonja R. Surman
Sonja R. Surman · 1×

Countries citing papers authored by Sonja R. Surman

Since Specialization
Citations

This map shows the geographic impact of Sonja R. Surman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonja R. Surman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonja R. Surman more than expected).

Fields of papers citing papers by Sonja R. Surman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonja R. Surman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonja R. Surman. The network helps show where Sonja R. Surman may publish in the future.

Co-authorship network of co-authors of Sonja R. Surman

This figure shows the co-authorship network connecting the top 25 collaborators of Sonja R. Surman. A scholar is included among the top collaborators of Sonja R. Surman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonja R. Surman. Sonja R. Surman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Human parainfluenza virus 3 vaccine candidates attenuated by codon-pair deoptimization are immunogenic and protective in hamsters
2024 ·Proceedings of the National Academy of Sciences ·(unknown), Sirle Saul, Jin Dai, Sonja R. Surman, Xueqiao Liu, Hong-Su Park, Cyril Le Nouën, (unknown), (unknown), J. Robert Coleman, Steffen Mueller, Peter L. Collins, Ursula J. Buchholz, Shirin Munir
2
2
Human parainfluenza virus type 3 expressing the respiratory syncytial virus pre-fusion F protein modified for virion packaging yields protective intranasal vaccine candidates
2020 ·PLoS ONE ·Xueqiao Liu, Bo Liang, Xiang Liu, Emérito Amaro-Carambot, Sonja R. Surman, Peter D. Kwong, Barney S. Graham, Peter L. Collins, Shirin Munir
17
3
The alpha-1 subunit of the Na+,K+-ATPase (ATP1A1) is required for macropinocytic entry of respiratory syncytial virus (RSV) in human respiratory epithelial cells
2019 ·PLoS Pathogens ·(unknown), Thomas McCarty, Xueqiao Liu, Ursula J. Buchholz, Sonja R. Surman, Scott E. Martin, Peter L. Collins, Shirin Munir
35
4
Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F
2017 ·Journal of Virology ·Xiang Liu, Bo Liang, Joan O. Ngwuta, Xueqiao Liu, Sonja R. Surman, (unknown), Peter D. Kwong, Barney S. Graham, Peter L. Collins, Shirin Munir
13
5
The C Proteins of Human Parainfluenza Virus Type 1 Block IFN Signaling by Binding and Retaining Stat1 in Perinuclear Aggregates at the Late Endosome
2012 ·PLoS ONE ·(unknown), (unknown), Jim Boonyaratanakornkit, Sonja R. Surman, Emérito Amaro-Carambot, Peter L. Collins, Alexander C. Schmidt
21
6
The cDNA-derived Investigational Human Parainfluenza Virus Type 3 Vaccine rcp45 Is Well Tolerated, Infectious, and Immunogenic in Infants and Young Children
2011 ·The Pediatric Infectious Disease Journal ·Ruth A. Karron, (unknown), Bhagvanji Thumar, Sonja R. Surman, Brian R. Murphy, Peter L. Collins, Alexander C. Schmidt
12
7
An improved method for the recovery of recombinant paramyxovirus vaccine candidates suitable for use in human clinical trials
2007 ·Journal of Virological Methods ·Sonja R. Surman, Peter L. Collins, Brian R. Murphy, Mario H. Skiadopoulos
11
8
Attenuation and efficacy of human parainfluenza virus type 1 (HPIV1) vaccine candidates containing stabilized mutations in the P/C and L genes
2007 ·Virology Journal ·Emmalene J. Bartlett, (unknown), Sonja R. Surman, Peter L. Collins, Mario H. Skiadopoulos, Brian R. Murphy
19
9
Recombinant human parainfluenza virus type 2 vaccine candidates containing a 3′ genomic promoter mutation and L polymerase mutations are attenuated and protective in non-human primates
2007 ·Vaccine ·Sheila M. Nolan, Mario H. Skiadopoulos, Konrad C. Bradley, (unknown), (unknown), Emérito Amaro-Carambot, Sonja R. Surman, Stephanie D. Davis, Marisa St. Claire, (unknown), Peter L. Collins, Brian R. Murphy, Nicolaas Schaap
14
10
Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1
2006 ·Virology ·Wil Van Cleve, Emérito Amaro-Carambot, Sonja R. Surman, Joseph Bekisz, Peter L. Collins, Kathryn C. Zoon, Brian R. Murphy, Mario H. Skiadopoulos, Emmalene J. Bartlett
34
11
Live-attenuated intranasal parainfluenza virus type 2 vaccine candidates developed by reverse genetics containing L polymerase protein mutations imported from heterologous paramyxoviruses
2005 ·Vaccine ·Sheila M. Nolan, Sonja R. Surman, Emérito Amaro-Carambot, Peter L. Collins, Brian R. Murphy, Mario H. Skiadopoulos
17
12
Introducing point and deletion mutations into the P/C gene of human parainfluenza virus type 1 (HPIV1) by reverse genetics generates attenuated and efficacious vaccine candidates
2005 ·Vaccine ·Emmalene J. Bartlett, Emérito Amaro-Carambot, Sonja R. Surman, Peter L. Collins, Brian R. Murphy, Mario H. Skiadopoulos
23
13
Human parainfluenza virus type I (HPIV1) vaccine candidates designed by reverse genetics are attenuated and efficacious in African green monkeys
2005 ·Vaccine ·Emmalene J. Bartlett, Emérito Amaro-Carambot, Sonja R. Surman, Jason T. Newman, Peter L. Collins, Brian R. Murphy, Mario H. Skiadopoulos
34
14
Sendai Virus, a Murine Parainfluenza Virus Type 1, Replicates to a Level Similar to Human PIV1 in the Upper and Lower Respiratory Tract of African Green Monkeys and Chimpanzees
2002 ·Virology ·Mario H. Skiadopoulos, Sonja R. Surman, Jeffrey M. Riggs, William R. Elkins, Marisa St. Claire, Machiko Nishio, Dominique Garcin, Daniel Kolakofsky, Peter L. Collins, Brian R. Murphy
38
15
The recombinant chimeric human parainfluenza virus type 1 vaccine candidate, rHPIV3–1cp45, is attenuated, immunogenic, and protective in African green monkeys
2002 ·Vaccine ·Mario H. Skiadopoulos, Joanne M. Tatem, Sonja R. Surman, (unknown), (unknown), William R. Elkins, Brian R. Murphy
13
16
Sequence Analysis of the Washington/1964 Strain of Human Parainfluenza Virus Type 1 (HPIV1) and Recovery and Characterization of Wild-Type Recombinant HPIV1 Produced by Reverse Genetics
2002 ·Virus Genes ·Jason T. Newman, Sonja R. Surman, Jeffrey M. Riggs, (unknown), Peter L. Collins, Brian R. Murphy, Mario H. Skiadopoulos
43
17
Evaluation of the Replication and Immunogenicity of Recombinant Human Parainfluenza Virus Type 3 Vectors Expressing up to Three Foreign Glycoproteins
2002 ·Virology ·Mario H. Skiadopoulos, Sonja R. Surman, Jeffrey M. Riggs, Claes Örvell, Peter L. Collins, Brian R. Murphy
46
18
Construction of a live-attenuated bivalent vaccine virus against human parainfluenza virus (PIV) types 1 and 2 using a recombinant PIV3 backbone
2001 ·Vaccine ·Tao Tao, Mario H. Skiadopoulos, (unknown), Sonja R. Surman, Peter L. Collins, Brian R. Murphy
9
19
Long Nucleotide Insertions between the HN and L Protein Coding Regions of Human Parainfluenza Virus Type 3 Yield Viruses With Temperature-Sensitive and Attenuation Phenotypes
2000 ·Virology ·Mario H. Skiadopoulos, Sonja R. Surman, Anna P. Durbin, Peter L. Collins, Brian R. Murphy
35
20
Attenuation of the Recombinant Human Parainfluenza Virus Type 3 cp45 Candidate Vaccine Virus Is Augmented by Importation of the Respiratory Syncytial Virus cpts530 L Polymerase Mutation
1999 ·Virology ·Mario H. Skiadopoulos, Sonja R. Surman, Marisa St. Claire, William R. Elkins, Peter L. Collins, Brian R. Murphy
32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valerie B. Randolph Breakdown of academic impact, for papers by Roderick S. Tang Breakdown of academic impact, for papers by Cai-Yen Firestone Breakdown of academic impact, for papers by Josephine M. McAuliffe Breakdown of academic impact, for papers by Mary Lou Clements‐Mann Breakdown of academic impact, for papers by R M Chanock Breakdown of academic impact, for papers by Selma Yüksel Breakdown of academic impact, for papers by Loïc Legrand Breakdown of academic impact, for papers by Joshua M. DiNapoli Breakdown of academic impact, for papers by Brian R. Murphy
Rankless by CCL
2026